- Companies
- Edifecs
Edifecs Acquisition, Valuation, Funding & Investors
Edifecs was acquired by Cotiviti for $3B in February 2025.
Edifecs acquisition price
$3B
Acquired by Cotiviti · Feb 2025
Key investors in Edifecs
Francisco Partners
TA Associates
About Edifecs
Edifecs is a Bellevue, Washington-headquartered provider of healthcare interoperability software. The SpecBuilder platform enables transaction validation for HIPAA 5010, ICD-10, and X12 EDI standards between payers, providers, and pharmacies. Edifecs serves Blue Cross Blue Shield plans and hospitals like Cleveland Clinic for claims processing and prior authorizations. Founded in 1996, it processes billions of transactions annually through cloud and on-premise deployments. Recent expansions include FHIR APIs for value-based care.
Founded
1996
HQ
Website
Status
Acquired
Customer focus
B2B
Revenue model
Subscription
Valuation
$1.4B (Jul 2020)
Edifecs Acquisition
Edifecs was acquired by Cotiviti for $3B on 10 February 2025.
| Acquirer | Date | Type | Price |
|---|---|---|---|
| 10 Feb 2025 | PE buyout | $3B |
Edifecs Valuation
Edifecs is currently valued at $1.4B, based on its undisclosed-stage round in July 2020. Read the announcement ↗
The round was led by Francisco Partners and TA Associates.
Edifecs valuation by funding round
| Date | Stage | Valuation |
|---|---|---|
| Jul 2020 | Undisclosed stage | $1.4B |
Edifecs Funding History
Edifecs has raised 1 funding round.
| Date | Stage | Investors | Valuation | Deal Summary |
|---|---|---|---|---|
| Jul 2020 | Undisclosed stage | Francisco Partners (lead); TA Associates (lead) | $1.4B | TA Associates and Francisco Partners announced a significant growth investment in Edifecs in July 2020, with closing expected in the third quarter of 2020. Financial terms were not disclosed in the announcement, though press reports pegged the deal at about $1.4 billion. The investors said the capital would support Edifecs' continued product development and expansion in the healthcare market. Edifecs provides interoperability, workflow, value-based care payment and analytics software to the U.S. healthcare market. More than 350 healthcare customers use its solutions, including payers, providers, employers, third-party administrators and government agencies. The company was founded in 1996 by Gurpreet (Sunny) Singh, is headquartered in Bellevue, Washington, and has more than 600 employees, with offices in Atlanta, Mohali and an engineering center in Moldova. |
Who has invested in Edifecs?
2 investors have backed Edifecs across its funding rounds, including Francisco Partners and TA Associates.
Lead investors include Francisco Partners and TA Associates.
Edifecs Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
This data is available for Pro users. Sign up to see all 2 Edifecs investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAcquisitions by Edifecs
Edifecs has acquired 2 companies to date.
Last acquisition by Edifecs was on November 22nd 2021. Edifecs acquired Health Fidelity for $180M.
Latest Acquisitions by Edifecs
| Description | Health Fidelity is a San Francisco-headquartered provider of NLP-powered risk adjustment solutions for Medicare Advantage, ACA, Medicaid, and ACOs. Its Lumanent suite extracts HCCs from unstructured clinical notes with 95% accuracy. The platform serves 50+ health plans covering 20 million lives. Health Fidelity integrates with Optum and Elevance Health systems. Founded in 2014, it supports value-based care revenue optimization. | Talix is a risk adjustment, quality, and oncology solutions provider helping providers, payers, and life science organizations succeed in value-based healthcare. The Talix SaaS platform leverages purpose-built natural language processing, machine learning, and advanced patient data analytics to transform complex data into actionable intelligence. Solutions drive improved efficiency and accuracy for better patient outcomes, more accurate reimbursements, and reduced costs. |
| HQ Country | ||
| HQ City | San Francisco, CA | San Francisco, CA |
| Deal Date | 22 Nov 2021 | 13 Sep 2021 |
| Valuation | $180M | undisclosed |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Edifecs acquisitions and their M&A valuation multiples. Start Free Trial | ||
Edifecs Competitors
Edifecs competitors include listed companies like Privia Health and Schrödinger, and private ones like Chapter, Grow Therapy, Saviynt and Cedar.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | - | - | $3B | - | ||
| Private | $1B | - | $3B | - | ||
| Private | $200M | - | $3B | 15.0x | ||
| Publicly listed | $2.1B | $44M | $3.1B | 1.1x | ||
| Private | - | - | $3.2B | - | ||
| Publicly listed | $256M | ($96M) | $2.2B | 7.7x |
Edifecs Public Comps
Edifecs is no longer listed, but its public comps include Privia Health, Tieto, Schrödinger, Qingdao Baheal Medical, Omnicell, Indegene, U.S. Physical Therapy, CCC Intelligent Solutions, EverCommerce and Vitec Software.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $2.1B | $44M | 1.3x | 1.1x | 62.1x | 18.2x | |||
| $2.1B | $182M | 1.3x | 1.4x | 15.3x | 7.5x | |||
| $256M | ($96M) | 7.7x | 7.7x | (20.4x) | (16.7x) | |||
| $1.1B | $140M | 2.1x | 2.1x | 16.6x | 18.5x | |||
| $1.2B | $92M | 1.4x | 1.3x | 17.5x | 8.7x | |||
| $373M | $69M | 3.8x | 3.3x | 20.7x | 18.3x | |||
| $781M | $110M | 2.8x | 2.6x | 20.3x | 21.6x | |||
| $1.1B | $238M | 4.3x | 4.0x | 19.1x | 9.4x | |||
This data is available for Pro users. Sign up to see all Edifecs competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Edifecs
| When was Edifecs founded? | Edifecs was founded in 1996. |
| Where is Edifecs headquartered? | Edifecs is headquartered in Seattle, WA, United States. |
| Is Edifecs publicly listed? | No, Edifecs was acquired by Cotiviti in February 2025. |
| Who acquired Edifecs? | Edifecs was acquired by Cotiviti in February 2025. |
| How much was Edifecs acquired for? | Edifecs was acquired for $3B in February 2025. |
| What is Edifecs' valuation? | Edifecs was last valued at $1.4B in its undisclosed-stage round in July 2020. |
| What was Edifecs' last funding round? | Edifecs' last funding round was a undisclosed-stage round in July 2020, led by Francisco Partners and TA Associates. |
| Who are Edifecs' investors? | Edifecs' investors include TA Associates and Francisco Partners. |
| Which companies are comparable to Edifecs? | Companies comparable to Edifecs include Chapter, Grow Therapy, Saviynt, Privia Health, Cedar and Schrödinger. |
| How many companies has Edifecs acquired? | Edifecs has acquired 2 companies, including Health Fidelity and Talix. |
| What was the largest acquisition by Edifecs? | The $180M acquisition of Health Fidelity in November 2021 is the largest acquisition Edifecs has made to date. |
See companies similar to Edifecs
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




